STOCK TITAN

Vanguard disaggregates holdings; reports 0 shares of Calumet Inc (CLMT)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed an amendment to Schedule 13G/A reporting 0 shares of Calumet Inc. The amendment notes an internal realignment on January 12, 2026 and explains that certain subsidiaries/business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538 (January 12, 1998). The filing is signed on 03/26/2026 and shows no sole or shared voting or dispositive power over Calumet common stock.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

Does The Vanguard Group report any CLMT shares after the amendment?

No. The filing states The Vanguard Group reports 0 shares of Calumet Inc common stock. It also reports 0 sole or shared voting and dispositive power in the disclosed items.

Why did Vanguard change how it reports its Calumet Inc holdings (CLMT)?

The filing attributes the change to an internal realignment on January 12, 2026. It says certain subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538 (January 12, 1998).

When was the Schedule 13G/A amendment for CLMT signed and filed?

The signature block shows the form was signed on 03/26/2026, and the amendment is labeled Amendment No. 1 with an internal date of 03/13/2026 referenced at the top of the excerpt.

Who signed the CLMT Schedule 13G/A amendment for Vanguard?

The filing is signed by Ashley Grim, whose title is listed as Head of Global Fund Administration. The signature date is shown as 03/26/2026.

Does the filing identify any third party with rights to dividends or sale proceeds for CLMT?

The filing states that The Vanguard Group, including managed accounts, have the right to receive or direct receipt of dividends or proceeds for the securities reported, but it also states no other person's interest reported exceeds 5% of the class.
Calumet

NASDAQ:CLMT

View CLMT Stock Overview

CLMT Rankings

CLMT Latest News

CLMT Latest SEC Filings

CLMT Stock Data

2.60B
67.64M
Specialty Chemicals
Petroleum Refining
Link
United States
INDIANAPOLIS